OCM and ovarian cancer: Consistently, western blot analysis suggested that knockout of TAK1 strongly reduced OCM-initiated activation of NF-κB signaling activities in ES-2 and MES-OV cells, confirming the importance of TAK1/NF-κB signaling for OCM-induced oncogenic properties in ovarian cancer (Figure 5C).